CAMBRIDGE, Mass., July 19,
2023 /PRNewswire/ -- Blueprint Medicines Corporation
(NASDAQ: BPMC) today announced that it will host a live conference
call and webcast at 8:00 a.m. ET on Wednesday, August 2, 2023, to report its second
quarter financial results and provide a corporate update.
To access the live conference call, please dial 833-470-1428
(domestic) or 404-975-4839 (international), and refer to conference
ID 669158. A webcast of the call will also be available under
"Events and Presentations" in the Investors & Media section of
the Blueprint Medicines website at
http://ir.blueprintmedicines.com/. The archived webcast will be
available on Blueprint Medicines' website approximately two hours
after the conference call and will be available for 30 days
following the call.
About Blueprint Medicines
Blueprint Medicines is a global precision therapy company that
invents life-changing therapies for people with cancer and blood
disorders. Applying an approach that is both precise and agile, we
create medicines that selectively target genetic drivers, with the
goal of staying one step ahead across stages of disease. Since
2011, we have leveraged our research platform, including expertise
in molecular targeting and world-class drug design capabilities, to
rapidly and reproducibly translate science into a broad pipeline of
precision therapies. Today, we are delivering our approved
medicines to patients in the United
States and Europe, and we
are globally advancing multiple programs for systemic mastocytosis,
lung cancer, breast cancer and other genomically defined cancers,
and cancer immunotherapy. For more information, visit
www.BlueprintMedicines.com and follow us on Twitter
(@BlueprintMeds) and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-second-quarter-2023-financial-results-on-wednesday-august-2-2023-301878911.html
SOURCE Blueprint Medicines Corporation